CH594703A5 - - Google Patents

Info

Publication number
CH594703A5
CH594703A5 CH952975A CH952975A CH594703A5 CH 594703 A5 CH594703 A5 CH 594703A5 CH 952975 A CH952975 A CH 952975A CH 952975 A CH952975 A CH 952975A CH 594703 A5 CH594703 A5 CH 594703A5
Authority
CH
Switzerland
Application number
CH952975A
Inventor
Alan Dinner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH594703A5 publication Critical patent/CH594703A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH952975A 1974-08-30 1975-07-21 CH594703A5 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US502131A US3920634A (en) 1974-08-30 1974-08-30 2,3-Dihydroestra-1,3,5(10)-trieno (16{60 ,17{60 -{62 ) furan-17{62 ols

Publications (1)

Publication Number Publication Date
CH594703A5 true CH594703A5 (zh) 1978-01-31

Family

ID=23996479

Family Applications (1)

Application Number Title Priority Date Filing Date
CH952975A CH594703A5 (zh) 1974-08-30 1975-07-21

Country Status (11)

Country Link
US (1) US3920634A (zh)
JP (1) JPS5141349A (zh)
BE (1) BE832498A (zh)
CA (1) CA1039268A (zh)
CH (1) CH594703A5 (zh)
DE (1) DE2536399A1 (zh)
FR (1) FR2282900A1 (zh)
GB (1) GB1515017A (zh)
IE (1) IE41296B1 (zh)
IL (1) IL47507A (zh)
NL (1) NL7510204A (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
DE10048634A1 (de) * 2000-09-27 2002-04-18 Jenapharm Gmbh 19-Nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21, 16alpha-Laktonring
DE10214180A1 (de) * 2002-03-27 2003-10-16 Schering Ag 11beta-lankgettig-substituierte 19-Nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21,16alpha-Laktonring

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3045012A (en) * 1960-06-02 1962-07-17 Abbott Lab Steroids containing a 16/17-lactone ring
US3089874A (en) * 1961-05-31 1963-05-14 Abbott Lab Steroid lactones
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids

Also Published As

Publication number Publication date
DE2536399A1 (de) 1976-03-11
IL47507A0 (en) 1975-08-31
IL47507A (en) 1978-08-31
JPS5141349A (en) 1976-04-07
IE41296B1 (en) 1979-12-05
CA1039268A (en) 1978-09-26
BE832498A (fr) 1976-02-18
NL7510204A (nl) 1976-03-02
GB1515017A (en) 1978-06-21
FR2282900B1 (zh) 1978-11-10
FR2282900A1 (fr) 1976-03-26
US3920634A (en) 1975-11-18
IE41296L (en) 1976-02-29

Similar Documents

Publication Publication Date Title
AU480152B2 (zh)
AU495841B2 (zh)
FR2282900B1 (zh)
AU8191875A (zh)
BG21143A1 (zh)
AU480469A (zh)
AU480069A (zh)
BG21094A1 (zh)
BG21122A1 (zh)
AU481898A (zh)
AU482332A (zh)
AU482369A (zh)
BE827113A (zh)
BE829575A (zh)
BE830029A (zh)
BG19710A1 (zh)
BG19722A1 (zh)
BG19729A1 (zh)
BG19867A1 (zh)
BG20001A1 (zh)
BG20146A1 (zh)
BG20212A1 (zh)
BG20237A1 (zh)
BG20430A1 (zh)
BG20475A1 (zh)

Legal Events

Date Code Title Description
PL Patent ceased